These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 20229271)

  • 1. Preventing chemoresistance of human breast cancer cell line, MCF-7 with celecoxib.
    Chen C; Shen HL; Yang J; Chen QY; Xu WL
    J Cancer Res Clin Oncol; 2011 Jan; 137(1):9-17. PubMed ID: 20229271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Celecoxib enhances doxorubicin-induced cytotoxicity in MDA-MB231 cells by NF-kappaB-mediated increase of intracellular doxorubicin accumulation.
    van Wijngaarden J; van Beek E; van Rossum G; van der Bent C; Hoekman K; van der Pluijm G; van der Pol MA; Broxterman HJ; van Hinsbergh VW; Löwik CW
    Eur J Cancer; 2007 Jan; 43(2):433-42. PubMed ID: 17097285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanism of suppression of MDR1 by puerarin from Pueraria lobata via NF-kappaB pathway and cAMP-responsive element transcriptional activity-dependent up-regulation of AMP-activated protein kinase in breast cancer MCF-7/adr cells.
    Hien TT; Kim HG; Han EH; Kang KW; Jeong HG
    Mol Nutr Food Res; 2010 Jul; 54(7):918-28. PubMed ID: 20077420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PSC833, cyclosporine analogue, downregulates MDR1 expression by activating JNK/c-Jun/AP-1 and suppressing NF-kappaB.
    Bark H; Choi CH
    Cancer Chemother Pharmacol; 2010 May; 65(6):1131-6. PubMed ID: 19763573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of combination of taxol and celecoxib on reversing multidrug resistance human breast cancer cells (MCF-7/ Taxol) and explore its underlying mechanism].
    Liu Q; Liu XJ; Chen YJ; Wang J
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 May; 42(3):326-30, 357. PubMed ID: 21826992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression.
    Zatelli MC; Luchin A; Tagliati F; Leoni S; Piccin D; Bondanelli M; Rossi R; degli Uberti EC
    Endocr Relat Cancer; 2007 Dec; 14(4):1029-38. PubMed ID: 18045954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Topoisomerase inhibitor upregulates MICA/B expression in breast cancer cells through ATM/ATR and NF-κB pathway].
    Zhu Y; Shi YJ; Zhao YL; Zhu P
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Apr; 50(2):318-325. PubMed ID: 29643533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased AP-1 activity in drug resistant human breast cancer MCF-7 cells.
    Daschner PJ; Ciolino HP; Plouzek CA; Yeh GC
    Breast Cancer Res Treat; 1999 Feb; 53(3):229-40. PubMed ID: 10369069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin inhibits P-glycoprotein expression via the NF-κB pathway and CRE transcriptional activity through AMPK activation.
    Kim HG; Hien TT; Han EH; Hwang YP; Choi JH; Kang KW; Kwon KI; Kim BH; Kim SK; Song GY; Jeong TC; Jeong HG
    Br J Pharmacol; 2011 Mar; 162(5):1096-108. PubMed ID: 21054339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Celecoxib induces apoptosis in cervical cancer cells independent of cyclooxygenase using NF-kappaB as a possible target.
    Kim SH; Song SH; Kim SG; Chun KS; Lim SY; Na HK; Kim JW; Surh YJ; Bang YJ; Song YS
    J Cancer Res Clin Oncol; 2004 Sep; 130(9):551-60. PubMed ID: 15197583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Celecoxib induced apoptosis against different breast cancer cell lines by down-regulated NF-κB pathway.
    Wang G; Li J; Zhang L; Huang S; Zhao X; Zhao X
    Biochem Biophys Res Commun; 2017 Aug; 490(3):969-976. PubMed ID: 28666869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of FoxO1 activation in MDR1 expression in adriamycin-resistant breast cancer cells.
    Han CY; Cho KB; Choi HS; Han HK; Kang KW
    Carcinogenesis; 2008 Sep; 29(9):1837-44. PubMed ID: 18390843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Key role of nuclear factor-κB in the cellular pharmacokinetics of adriamycin in MCF-7/Adr cells: the potential mechanism for synergy with 20(S)-ginsenoside Rh2.
    Zhang J; Lu M; Zhou F; Sun H; Hao G; Wu X; Wang G
    Drug Metab Dispos; 2012 Oct; 40(10):1900-8. PubMed ID: 22745335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The nonsteroidal anti-inflammatory drug celecoxib suppresses the growth and induces apoptosis of human glioblastoma cells via the NF-κB pathway.
    Sareddy GR; Geeviman K; Ramulu C; Babu PP
    J Neurooncol; 2012 Jan; 106(1):99-109. PubMed ID: 21847707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Celecoxib potently inhibits TNFalpha-induced nuclear translocation and activation of NF-kappaB.
    Funakoshi-Tago M; Shimizu T; Tago K; Nakamura M; Itoh H; Sonoda Y; Kasahara T
    Biochem Pharmacol; 2008 Sep; 76(5):662-71. PubMed ID: 18644347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cucurbitacin D induces cell cycle arrest and apoptosis by inhibiting STAT3 and NF-κB signaling in doxorubicin-resistant human breast carcinoma (MCF7/ADR) cells.
    Ku JM; Kim SR; Hong SH; Choi HS; Seo HS; Shin YC; Ko SG
    Mol Cell Biochem; 2015 Nov; 409(1-2):33-43. PubMed ID: 26169986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of methionine adenosyltransferase 2A in tamoxifen-resistant breast cancer cells.
    Phuong NT; Kim SK; Im JH; Yang JW; Choi MC; Lim SC; Lee KY; Kim YM; Yoon JH; Kang KW
    Oncotarget; 2016 Mar; 7(12):13902-16. PubMed ID: 26418898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Celecoxib inhibits MDR1 expression through COX-2-dependent mechanism in human hepatocellular carcinoma (HepG2) cell line.
    Roy KR; Reddy GV; Maitreyi L; Agarwal S; Achari C; Vali S; Reddanna P
    Cancer Chemother Pharmacol; 2010 Apr; 65(5):903-11. PubMed ID: 19685055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Celecoxib, a cyclooxygenase-2 inhibitor, potentiates the chemotherapic effect of vinorelbine in the medullary thyroid cancer TT cell line.
    Vivaldi A; Ciampi R; Tacito A; Molinaro E; Agate L; Bottici V; Pinchera A; Collecchi P; Elisei R
    Mol Cell Endocrinol; 2012 May; 355(1):41-8. PubMed ID: 22305971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Forced expression of heat shock protein 27 (Hsp27) reverses P-glycoprotein (ABCB1)-mediated drug efflux and MDR1 gene expression in Adriamycin-resistant human breast cancer cells.
    Kanagasabai R; Krishnamurthy K; Druhan LJ; Ilangovan G
    J Biol Chem; 2011 Sep; 286(38):33289-300. PubMed ID: 21784846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.